Snowball logo
logo
VYT

Vytrus Biotech S.A.

VYT MC
16.15-0.45  (2.71%)
Estimate
P/E
41.4
EPS
0.39
Beta
-0.11
Forecast
P/E (FWD)
27.2
EPS (FWD)
0.594
About the company
Ticker
VYT
ISIN
ES0105618005
Country
Spain
Sector (GICS)
Healthcare
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and protects against oxidative stress. The company also provides Baolift that improves muscle tone and facial complexion; Elaya Renova that boosts hair tensegrity; Kannabia Sense, a prebiotic treatment that stimulates the skin microbiota to produce an in-situ postbiotic cocktail; Quora Noni to avoid the attack of skin harmful bacteria; Centella Reversa for facial complexion improvement; and Arabian Cotton to protect and repair cell structures against sun damage. In addition, it offers Photobiome, a prebiotic active that fights the skin photoageing process; Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Olea Vitae, a cellular oil against ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; and Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins. Further, the company provides technology solutions, such as plasma rich in cell factors; phyto-peptidic, phyto-lipidic, and phyto-glucidic fractions; and phyto-cell fusions, as well as Vytrus TV to create an audiovisual space with added value for cosmetic formulation. It exports its products. Vytrus Biotech, S.A. was incorporated in 2009 and is headquartered in Barcelona, Spain.

Frequently asked questions

What sector does Vytrus Biotech S.A. (VYT) operate in?

Vytrus Biotech S.A. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Vytrus Biotech S.A. (VYT) current stock price?

As of the latest data, Vytrus Biotech S.A. stock price is €16.15, with a previous close of €16.60. Vytrus Biotech S.A. lost -€0.45 in the last trading session, representing a -2.71% loss.

What is Vytrus Biotech S.A. (VYT) current market capitalization?

Vytrus Biotech S.A. market cap is approximately 121.39 million.

What is Vytrus Biotech S.A. (VYT) Earnings Per Share (EPS)?

The trailing EPS is €0.39, and the forward EPS is €0.59.

What is Vytrus Biotech S.A. (VYT) Price-to-Earnings (P/E) ratio?

Vytrus Biotech S.A. current P/E ratio is 41.41, with a forward P/E of 27.2.

Does Vytrus Biotech S.A. (VYT) pay dividends?

No. Vytrus Biotech S.A. does not pay a dividend.

What is Vytrus Biotech S.A. (VYT) beta (volatility) score?

Vytrus Biotech S.A. has a beta of -0.110, indicating lower volatility than the overall market.